Cargando…
Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 ((64)Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic (64)Cu content after oral (64)Cu administration and test if alternative regime...
Autores principales: | Munk, Ditte Emilie, Lund Laursen, Tea, Teicher Kirk, Frederik, Vilstrup, Hendrik, Ala, Aftab, Gormsen, Lars Christian, Ott, Peter, Damgaard Sandahl, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424214/ https://www.ncbi.nlm.nih.gov/pubmed/36038585 http://dx.doi.org/10.1038/s41598-022-18872-8 |
Ejemplares similares
-
Distribution of non-ceruloplasmin-bound copper after i.v. (64)Cu injection studied with PET/CT in patients with Wilson disease
por: Munk, Ditte Emilie, et al.
Publicado: (2023) -
Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years
por: Kirk, Frederik Teicher, et al.
Publicado: (2022) -
Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [(64)Cu]copper PET/CT
por: Kjærgaard, Kristoffer, et al.
Publicado: (2020) -
High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018) -
The pathophysiology of Wilson’s disease visualized: A human (64)Cu PET study
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2022)